| 000 | 00849 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517105526.0 | ||
| 264 | 0 | _c20160824 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/535355d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDing, Xianting | |
| 245 | 0 | 0 |
_aDrug screening: Drug repositioning needs a rethink. _h[electronic resource] |
| 260 |
_bNature _c07 2016 |
||
| 300 |
_a355 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aDrug Repositioning _xmethods |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tNature _gvol. 535 _gno. 7612 _gp. 355 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/535355d _zAvailable from publisher's website |
| 999 |
_c26252020 _d26252020 |
||